GSK, Daiichi Sankyo to co-promote Rotarix in Japan
Clinical trials conducted in Japan and overseas have confirmed that Rotarix prevents severe rotavirus gastroenteritis and all rotavirus gastroenteritis. The Ministry of Health, Labour and Welfare (MHLW) has
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.